This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astra Zeneca U.k. Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Qibin Su: Innovator in Selective Inhibitors
Introduction
Qibin Su is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors. His work is recognized for its potential impact on therapeutic applications.
Latest Patents
Qibin Su holds a patent for "JAK1 Selective Inhibitors." This innovation is crucial in the ongoing research and development of treatments targeting specific pathways in various diseases.
Career Highlights
Currently, Qibin Su is employed at AstraZeneca UK Limited, a leading global biopharmaceutical company. His role involves advancing research initiatives that align with the company's mission to deliver innovative medicines.
Collaborations
Throughout his career, Qibin has collaborated with esteemed colleagues, including Karl Magnus Nilsson and Annika Birgitta Margareta Åstrand. These partnerships have fostered a collaborative environment that enhances the quality of research and development.
Conclusion
Qibin Su's contributions to the field of selective inhibitors exemplify the importance of innovation in pharmaceuticals. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile